CIK 0000921299 · Non-accelerated filer<br>Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770357827
- Phone
- 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-07 | Schoeneck James A Director | Sale 10b5-1 | −7,100 | $18.03 | $128K | 73,722 |
| 2023-06-07 | Schoeneck James A Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +12,666 | 12,666 | ||
| 2023-06-07 | Wettig Thane Chief Commercial Officer | Sale | −472 | $17.04 | $8K | 112,681 |
| 2023-06-07 | Wettig Thane Chief Commercial Officer | Sale | −1,286 | $17.04 | $22K | 111,395 |
| 2023-06-07 | Graham Juan Chief Financial Officer | Sale | −1,050 | $16.95 | $18K | 71,818 |
| 2023-06-07 | Graham Juan Chief Financial Officer | Sale | −735 | $17.04 | $13K | 71,083 |
| 2023-06-07 | Chung Christine SVP, China Operations | Sale | −1,362 | $17.04 | $23K | 251,098 |
| 2023-06-07 | Chung Christine SVP, China Operations | Sale | −739 | $17.04 | $13K | 250,359 |
| 2023-06-07 | Chung Christine SVP, China Operations | Sale | −1,532 | $17.04 | $26K | 248,827 |
| 2023-06-07 | Eisner Mark EVP, Chief Medical Officer | Sale | −2,042 | $17.04 | $35K | 162,862 |
| 2023-06-07 | Conterno Enrique A Chief Executive Officer | Sale | −2,791 | $17.04 | $48K | 382,708 |
| 2023-06-07 | Conterno Enrique A Chief Executive Officer | Sale | −6,106 | $17.04 | $104K | 376,602 |
| 2023-06-02 | Eisner Mark EVP, Chief Medical Officer | Sale | −1,090 | $18.83 | $21K | 164,904 |
| 2023-04-10 | Conterno Enrique A Chief Executive Officer | Sale | −1,869 | $19.52 | $36K | 382,999 |
| 2023-04-04 | Eisner Mark Chief Medical Officer | Sale | −9,182 | $18.78 | $172K | 165,994 |
| 2023-04-04 | Chung Christine SVP, China Operations | Sale | −6,590 | $18.78 | $124K | 252,460 |
Page 8 of 8 · 156 trades